Trevi Therapeutics Inc (NASDAQ: TRVI): Stock That Needs Special Handling
Currently, there are 99.89M common shares owned by the public and among those 59.67M shares have been available to trade. The company’s stock has a 5-day price change of 0.40% and 48.24% over the past three months. TRVI shares are trading 53.28% year to date (YTD), with the 12-month market performance up to 148.62% higher. […]